HARVARD BIOSCIENCE, INC. Unamortized Debt Issuance Expense
HARVARD BIOSCIENCE, INC. (HBIO) had Unamortized Debt Issuance Expense of -$151.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2018-03-16
- 2017-12-31: Unamortized Debt Issuance Expense -$151.00K.
- 2016-12-31: Unamortized Debt Issuance Expense -$104.00K.
- 2016-09-30: Unamortized Debt Issuance Expense -$120.00K.
- 2016-06-30: Unamortized Debt Issuance Expense -$112.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2017-12-31 | -$151.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | -$104.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | -$120.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$112.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$139.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$167.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |